1. Home
  2. Live Updates
  3. Regius professor of cancer research

Live Breaking News & Updates on Regius professor of cancer research

Stay informed with the latest breaking news from Regius professor of cancer research on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Regius professor of cancer research and stay connected to the pulse of your community

Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first '2 in 1' immune cell engager CB699 at AACR 2024

Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first '2 in 1' immune cell engager CB699 at AACR 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , London , City-of , Cambridge , Cambridgeshire , United-states , American , David-daley , Mary-jane-elliott , Sukaina-virji , Theodora-harold , Regius-professor-of-cancer-research

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023Interim data from...

San-diego , California , United-states , France , San-diego-convention-center , Volker-kunzmann , Institut-paoli-calmettes , Gretchen-schweitzer , Paul-frohna , Francois-xavier-danlos , Katrien-lemmens , Maelle-mairesse

ImCheck Presented Updated Positive Data from Phase I/IIa

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023 Interim data from...

San-diego , California , United-states , France , San-diego-convention-center , Maelle-mairesse , Institut-paoli-calmettes , Emmanuel-valentin , Paul-frohna , Patrick-brune , Francois-xavier-danlos , Martin-wermke

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023

ImCheck Presented Updated Positive Data from Phase I/IIa EVICTION-2 Trial of ICT01 in Combination with Low-dose IL-2 at SITC 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , France , San-diego , California , San-diego-convention-center , Katrien-lemmens , Volker-kunzmann , Francois-xavier-danlos , Patrick-brune , Institut-paoli-calmettes , Maelle-mairesse , Emmanuel-valentin

2023-09-07 | NDAQ:ONCT | Press Release | Oncternal Therapeutics Inc

(2023-09-07 | NDAQ:ONCT) Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board

Santa-monica , California , United-states , London , City-of , United-kingdom , Malta , San-diego , Greifswald , Mecklenburg-vorpommern , Germany , Minnesota

Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board

Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Santa-monica , California , United-states , Malta , Germany , San-diego , London , City-of , United-kingdom , Greifswald , Mecklenburg-vorpommern , Minnesota

Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board

Scientific Advisory Board members bring significant global expertise in oncology drug and clinical development

... | June 1, 2023

Baylor-university , Texas , United-states , New-york , Tufts-university , Massachusetts , Denmark , San-francisco , California , Copenhagen , Køavn- , Columbia-university

Hummingbird Bioscience Announces Trial in Progress Poster Presentation at the European Society for Medical Oncology Congress 2022

HMBD-001 is a proprietary anti-HER3 antibody in an ongoing Phase 1 trial targeting multiple solid tumors HMBD-001 has the potential to fully block...

Paris , France-general- , France , United-kingdom , Singapore , Jerome-boyd-kirkup , Nigel-blackburn , Youtube , European-society-for-medical-oncology-congress , Institute-of-cancer-research , Cancer-research-united-kingdom , Twitter

Merck's Keytruda significantly extends life in some prostate cancer patients

Merck's Keytruda significantly extends life in some prostate cancer patients
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Bristol-myers-squibb , Institute-of-cancer-research , Merck-co , Regius-professor-of-cancer-research , Johann-de-bono , Regius-professor , Cancer-research , Royal-marsden ,

Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

United-kingdom , United-states , London , City-of , Edna-kaplan , Paula-schwartz , Jessica-breu , Daniel-vitt , Research-ethics-committee , Regius-professor-of-cancer-research , Rx-communications-group , Nasdaq